MLS(ASCP) Certification: Laboratory Decisions and Practice Guide Study Guide

Apply it

An adult's red cells react with anti-A but not anti-B, and the plasma reacts with B cells only. Recognize a concordant group A pattern before evaluating Rh typing and the antibody screen.

Apply it

Forward typing suggests group A, but reverse typing reacts with both A and B reagent cells. Verify identity and investigate the unexpected reaction; do not simply overwrite the reverse result to match the forward type.

Apply it

A patient with historical anti-K now has a negative screen. Select appropriately compatible K-negative cells and use the serologic compatibility pathway; the negative screen does not restore eligibility for electronic crossmatching.

Apply it

A patient develops falling hemoglobin and biochemical evidence of hemolysis. Use direct antiglobulin testing to assess red-cell coating, while recognizing that an antibody screen addresses plasma reactivity and answers a different question.

Apply it

In a hypothetical panel, three Jk(a+b−) cells react 1+, a Jk(a+b+) cell is nonreactive, and three Jk(a−b+) cells are nonreactive. With other relevant antigens controlled, weak anti-Jka showing dosage explains the apparent contradiction: the nonreactive heterozygous cell does not exclude anti-Jka. Test additional selected Jk(a+b−) cells and appropriately matched Jka-negative cells, and establish that the patient lacks Jka using suitable phenotyping or genotyping before completing identification and antigen-negative unit selection.

Apply it

An RhD-negative woman has a negative antibody screen and needs a routine transfusion. Select RhD-negative red cells to avoid introducing the D antigen, while completing the remaining compatibility assessment.

Apply it

A group A patient has anti-E. Search for ABO-compatible E-negative donor red cells and complete the required serologic compatibility testing rather than selecting any available group A unit.

Apply it

A newborn's red cells type as group A, but plasma reactions do not match the usual adult group A pattern. Recognize the infant's age and possible maternal antibody contribution before interpreting the plasma findings or selecting donor cells.

Apply it

An unidentified bleeding patient requires red cells before testing is complete. Emergency-release group O cells address the unknown ABO group, while the laboratory continues testing for antibodies and prepares an informed transition to subsequent components.

Apply it

A transfusion order specifies irradiated red cells, and only leukoreduced units are immediately visible in inventory. Identify units meeting the irradiation requirement; leukoreduction alone does not address the donor-lymphocyte proliferation risk.

Apply it

A patient with a documented indication to minimize residual plasma requires red cells. Recognize washing as the relevant processing method and separately determine whether irradiation or other modifications are also required.

Apply it

A group A recipient needs plasma. Evaluate the antibodies in the proposed plasma component against the recipient's A antigen rather than transferring the familiar group O red-cell rule to plasma selection.

Apply it

Urine from a patient with substantial muscle injury has a positive blood pad but very few red cells microscopically. Consider pigment-associated reactivity and correlate with muscle injury testing instead of reporting microscopic hematuria from the pad alone.

Apply it

A symptomatic patient submits urine after frequent voiding. Nitrite is negative, but microscopy shows leukocytes and bacteria. Recognize that short bladder residence can limit nitrite formation and continue interpreting the combined findings.

Apply it

A patient with hematuria and proteinuria has cylindrical structures containing cells that resemble surrounding free erythrocytes. Identify red-cell casts and correlate the combined pattern with glomerular injury, rather than attributing the blood to a lower urinary tract source solely because erythrocytes are present.

Apply it

A needle-shaped crystal in synovial fluid from a swollen joint appears yellow with its long axis parallel to the compensator’s marked slow axis. Rotating the stage 90 degrees makes the crystal perpendicular and blue. This demonstrates negative birefringence and supports monosodium urate deposition in gout. A rhomboidal crystal that instead appears blue when parallel and yellow when perpendicular demonstrates positive birefringence and favors calcium pyrophosphate deposition disease.

Apply it

A difficult collection produces potassium of 8.1 mmol/L and markedly depressed calcium, while a fresh properly collected specimen is normal. Recognize additive contamination as a coherent explanation for the paired initial abnormalities.

Apply it

A visibly hemolyzed specimen has high potassium, but a carefully recollected nonhemolyzed specimen does not. Connect the discrepancy to potassium released after collection rather than assuming a rapid physiological correction occurred.

Apply it

Two aliquots originate from the same collection, but one remains with cells much longer before separation. Its lower glucose result is compatible with ongoing cellular consumption even when both analytical runs have acceptable quality control.

Apply it

A patient with active hemolysis has repeatedly elevated glucose measurements but a relatively low A1C. Recognize shortened red-cell survival as a reason the A1C may underrepresent glycemia and communicate the interpretive limitation.

Apply it

A patient with evidence of increased red-cell destruction has predominantly unconjugated hyperbilirubinemia. Link the pattern to increased bilirubin production while checking for competing hepatic explanations rather than diagnosing obstruction from total bilirubin alone.

Apply it

A bilirubin aliquot left exposed near a window produces a lower result than a promptly protected aliquot. Investigate light-related degradation before interpreting the difference as improvement in the patient's bilirubin concentration.

Apply it

Sodium is 140 mmol/L, chloride 104 mmol/L and bicarbonate 18 mmol/L. Calculate an anion gap of 18 mmol/L using the potassium-excluding formula, then interpret it against the appropriate laboratory interval.

Apply it

An arterial gas has pH 7.29, bicarbonate 14 mmol/L and PaCO2 30 mm Hg. Low bicarbonate explains the acidemia. Expected PaCO2 is 1.5 × 14 + 8 = 29 ± 2 mm Hg, so 30 is appropriate respiratory compensation. With the same bicarbonate but PaCO2 40 mm Hg, pH would be approximately 7.17; the higher-than-expected PaCO2 suggests an additional respiratory acidosis.

Apply it

An enzyme reaction begins linearly but later flattens. Examine whether the selected measurement interval remains valid and whether dilution or another validated analytical step is needed before accepting the calculated activity.

Apply it

Total cholesterol 200 mg/dL, HDL 50 mg/dL and triglycerides 150 mg/dL give LDL = 200 − 50 − 150/5 = 120 mg/dL. If another specimen has total cholesterol 260 mg/dL, HDL 40 mg/dL and triglycerides 500 mg/dL, arithmetic would yield 120 mg/dL again, but reject that Friedewald calculation because triglycerides exceed its applicability limit. Use a separately validated alternative method or equation.

Apply it

A validated competitive hormone assay produces a lower bound-label signal for one specimen than another. Use its inverse calibration curve to interpret concentration instead of ranking the specimens by raw signal intensity.

Apply it

A specimen labeled trough was collected shortly after the dose was administered. Identify the timing mismatch and obtain the actual dosing and collection record before comparing the result with a trough-based interpretive range.

Apply it

A hematocrit of 30% and red-cell count of 5.0 million/µL produce an MCV of 60 fL. Recognize microcytosis while using additional findings to distinguish its possible causes rather than naming a disease from MCV alone.

Apply it

In an illustrative specimen, hemoglobin is 12.0 g/dL, RBC count is 2.00 × 10^12/L and hematocrit is 24.0%; MCHC is 12.0 × 100/24.0 = 50.0 g/dL. The smear shows erythrocyte aggregates. Following warming at 37°C using the laboratory's validated procedure, prompt reanalysis gives RBC count 4.00 × 10^12/L, hematocrit 36.0% and unchanged hemoglobin, yielding MCHC 33.3 g/dL. Disappearance of aggregates on immediate smear reassessment supports temperature-dependent interference. In the manufacturer's documented case, MCHC decreased from 44.6 to 34.0 g/dL after warming, but the postwarming smear still showed some agglutination. Thus, numerical improvement and disappearance of an analyzer flag do not establish complete resolution.

Apply it

A WBC count of 2.0 × 10^9/L with 30% segmented neutrophils and 5% bands gives an ANC of 0.70 × 10^9/L. Use the absolute value rather than the combined 35% alone.

Apply it

An anemic patient has a reticulocyte percentage above the reference interval. Examine the absolute count and the degree of anemia before deciding that marrow production is robust enough to explain the clinical picture.

Apply it

Falling hemoglobin accompanies increased indirect bilirubin and LDH, low haptoglobin and an increased reticulocyte count. Recognize a hemolytic pattern and then investigate immune and nonimmune causes using history and targeted testing.

Apply it

One specimen shows granulocytes across maturation stages with basophilia; pursue BCR::ABL1 testing for suspected CML. Another contains numerous blasts with anemia and thrombocytopenia; arrange prompt hematopathology review and lineage-defining studies instead of assigning a lineage from total leukocyte count.

Apply it

A film shows fragmented red cells alongside anemia, thrombocytopenia and biochemical hemolysis. Recognize that this combination requires prompt assessment for a fragmentation process rather than labeling the anemia as immune solely from hemolysis markers.

Apply it

Compare two patients with isolated APTT prolongation that corrects on mixing. Factor VIII deficiency can produce clinically important bleeding, whereas factor XII deficiency can markedly prolong APTT without a bleeding phenotype. Factor assays distinguish these possibilities; the screening time alone does not predict bleeding. An isolated prolonged PT instead directs initial factor localization toward VII.

Apply it

For this hypothetical method, correction requires a mixture APTT of 38 seconds or less both immediately and after two hours at 37°C. Patient APTT is 72 seconds; the 1:1 mixture measures 34 seconds immediately and 35 seconds after incubation, with acceptable controls. This sustained correction supports factor deficiency. Factor VIII, IX and XI assays can investigate a bleeding presentation; factor XII deficiency is a consideration when bleeding is absent.

Apply it

Using an illustrative correction cutoff of 38 seconds or less at each time point, patient APTT is 84 seconds and the 1:1 mixture measures 34 seconds immediately but 66 seconds after two hours at 37°C. Incubated normal-plasma control is 34 seconds. With anticoagulant interference excluded, loss of correction supports a time-dependent inhibitor and directs testing toward factor VIII activity and inhibitor quantification.

Apply it

An EDTA specimen reports platelets of 42 × 10^9/L with a clump flag. Inspect the tube for clot and review the smear, including its feathered edge, for aggregates and fibrin. If clot or fibrin is found, request recollection rather than counting the remaining blood. If EDTA-dependent aggregation is suspected, an illustrative approach is collection into a properly filled sodium citrate tube, followed by timely analysis and smear assessment. If the citrate smear is free of aggregates and the measured count is 180 × 10^9/L, a method requiring correction for nine volumes of blood plus one volume of citrate gives 180 × 10/9 = 200 × 10^9/L. Verify whether the laboratory system already applies this correction. This example must be adapted to the laboratory's validated collection and counting method.

Apply it

One individual has anti-HBs alone, while another has anti-HBs and total anti-HBc; both lack HBsAg. Recognize vaccine-associated immunity in the first pattern and resolved natural infection in the second.

Apply it

A symptomatic patient has HBsAg, total anti-HBc and IgM anti-HBc, with no anti-HBs. Recognize a pattern compatible with acute infection while checking prior results and history for chronic infection with a flare.

Apply it

A donor and recipient have favorable HLA matching, but testing detects recipient antibody reactive with a donor antigen. Explain why antigen similarity does not override the separate evidence concerning donor-directed antibody.

Apply it

Low CH50 with normal AH50 supports testing classical-pathway components rather than assuming a terminal-component defect. If both screens are low, evaluate shared components and consumption. A single persistently deficient component favors a hereditary deficiency; reductions in multiple components can favor consumption. Confirm the mechanism with component testing and clinical findings.

Apply it

A superficial swab grows mixed organisms from a draining wound. Consider whether the collection represents surface colonization or the deeper process being investigated rather than assuming every recovered species is an invasive pathogen.

Apply it

An isolate has Gram-positive cocci in clusters, positive catalase, negative slide coagulase and beta-hemolytic colonies. A negative slide result does not exclude S. aureus. Perform tube coagulase and integrate the result with additional identification findings; a coagulase-negative result does not establish S. epidermidis.

Apply it

An isolate has a lower numerical MIC to one drug than another. Avoid ranking the drugs by those numbers alone; compare each result with its own applicable breakpoint and validated reporting framework.

Apply it

A respiratory specimen contains acid-fast bacilli. Recognize the finding as important, but use organism-specific testing and culture to establish whether the organism is M. tuberculosis complex rather than reporting tuberculosis from staining alone.

Apply it

A patient with strong clinical suspicion has a negative smear but undergoes organism-specific molecular testing and culture. Recognize why a negative microscopy result does not remove the need for these additional laboratory approaches.

Apply it

A patient remains molecularly positive after symptoms improve. Explain that target detection alone does not quantify infectious virus or establish ongoing transmission potential without an appropriate organism-specific interpretive framework and additional context.

Apply it

A returning traveler has fever and possible malaria. Examine an appropriate thick film for detection and a thin film for morphological assessment instead of selecting one preparation as a universal substitute for the other.

Apply it

A thin film contains delicate rings, several doubly infected red cells and peripheral ring forms. Recognize a pattern concerning for P. falciparum and integrate the full examination rather than waiting for crescent gametocytes.

Apply it

A thin-film count finds 45 infected red cells among 1,500 red cells. Calculate 45 ÷ 1,500 × 100 = 3.0% parasitemia, without increasing the numerator for multiply infected cells.

Apply it

An oval, four-nucleated structure in formed stool supports recognition of a mature Giardia cyst. A pear-shaped organism with two nuclei and an adhesive disk supports a trophozoite. If initial microscopy is negative despite compatible symptoms, use additional stool specimens for repeat examination or an appropriate stool antigen or direct fluorescent antibody assay.

Apply it

A patient receiving laxatives has a positive NAAT but a negative toxin assay. Recognize that colonization and noninfectious diarrhea remain possible; the molecular result alone does not establish that C. difficile explains the symptoms.

Apply it

A yeast isolate receives an unusual identification on a system known to misidentify C. auris. Seek confirmation using an appropriate validated identification method and follow the relevant laboratory communication pathway rather than accepting the first label.

Apply it

Control measurements have a mean of 100 units and a standard deviation of two units. Calculate a CV of 2%; then separately assess whether the mean agrees with an appropriate assigned target.

Apply it

A control produces tightly clustered values consistently above its assigned target. Investigate a systematic shift, such as calibration-related bias, rather than assuming that the tight clustering demonstrates satisfactory overall analytical performance.

Apply it

Both control levels shift above their established ranges after a reagent change. Hold affected reporting, investigate the change and demonstrate acceptable performance before deciding whether patient specimens require repeat analysis or other review.

Apply it

Mix 100 µL of specimen with 400 µL of diluent. A measured diluted concentration of 30 units corresponds to 150 units in the original specimen: total volume 500 µL ÷ specimen volume 100 µL = five; 30 × five = 150.

Apply it

A balanced run ends with suspected breakage inside a sealed carrier. Notify responsible personnel, maintain containment and transfer the closed carrier to the appropriate biological safety cabinet for opening. Follow the incident procedure for settling and decontamination. Remove broken glass with forceps or tongs into a suitable sharps container, never by hand.